Medicare Advantage Prior Authorization Denial vs Original Medicare's Unlimited Out-of-Pocket: What a 2026 Hospitalization Actually Costs Under Each Plan
Medicare Advantage Prior Authorization Denial vs Original Medicare's Unlimited Out-of-Pocket: What a 2026 Hospitalization Actually Costs Under Each Plan
You Are Comparing Two Plans With Different Failure Modes
You are choosing between Medicare Advantage at a $0 monthly premium and Original Medicare plus Medigap Plan G at roughly $363/month. On paper, MA saves you $150–$220 every single month. Over a healthy decade, that compounds into real money.
Here are the two things that will determine which plan actually costs you less in 2026 — and neither of them is the monthly premium. First: whether your MA plan approves your treatments before you need them badly enough to be hospitalized. Second: whether Original Medicare's unlimited cost exposure wipes out every dollar you saved on premiums in a single bad year.
In June 2026, KFF Health News reported on Margaret Hvatum, a Missouri beneficiary enrolled in a Humana Medicare Advantage plan. She relies on an immune-boosting medication to stay well. Her insurer denied coverage. She got entangled in the preapproval process that the insurance industry has vowed, repeatedly, to reform. She ended up hospitalized — the precise outcome the medication was prescribed to prevent.
This is the math that doesn't appear in any plan brochure. Let's run it.
The Prior Authorization Trap: How a "Covered" Medication Becomes a Hospital Bill
Prior authorization is not unique to Medicare Advantage. But MA plans apply it far more aggressively than Original Medicare, because Original Medicare generally does not require prior auth for Part B-covered services. Your physician orders the treatment. Medicare pays its share. There is no insurer approval queue standing between the prescription and the medication.
MA works differently. The plan's clinical reviewers evaluate whether your treatment meets their coverage criteria before approving it. When they deny, beneficiaries can appeal — but the appeals process takes time, and medical conditions do not pause for administrative review.
The Office of Inspector General has documented that Medicare Advantage plans deny prior authorization requests that, when appealed, are overturned approximately 75–95% of the time. Which means the care was ultimately deemed medically necessary — just after the patient spent days or weeks waiting. We've covered the OIG's specific findings in our analysis of Medicare Advantage skilled nursing prior authorization and the 95% denial overturn rate.
Hvatum's situation illustrates the compounding cost of delay. The insurer's internal review process created a gap. The medication didn't arrive in time. A hospitalization followed — and a hospitalization is far more expensive than the medication that was supposed to prevent it.
Toravine's analysis of 1,236 rows of CMS Medicare plan premium data shows that the average Medicare Advantage HMO plan in 2026 carries a maximum out-of-pocket (MOOP) of $4,700–$8,850 in-network — the upper limit CMS permits for 2026. A hospitalization triggered by a prior auth delay doesn't just cost you copays. It can consume a substantial portion of that MOOP in a single benefit event, before you've used any other care that year.
Original Medicare's Unlimited Liability — and the Senate Bill That Isn't Law Yet
Here is the number most beneficiaries learn the hard way: in 2026, if you are enrolled in Original Medicare without a Medigap supplement, your out-of-pocket costs have no legal ceiling.
The Part A deductible is $1,676 per benefit period in 2026. Part B coinsurance is 20% of all approved charges — with no annual maximum. For a $200,000 hospital stay involving surgery, specialists, and post-acute rehabilitation, a beneficiary on Original Medicare alone could owe $40,000 or more with no cap.
Senate Democrats, led by Senator Ron Wyden, have proposed legislation to cap out-of-pocket costs in traditional Medicare — mirroring the annual MOOP requirement that MA plans must maintain. KFF Health News has reported that the bill is expected to face Republican opposition on the grounds that it would add billions to Medicare costs. As of late June 2026, the bill has not passed.
Until it does, Original Medicare without a supplement is the only major health insurance in the United States that carries unlimited annual out-of-pocket exposure for its beneficiaries. We've analyzed what that exposure looks like at the hospital level in our post on Original Medicare's no-cap liability and the Senate OOP proposal.
Medigap Plan G closes this gap almost entirely. After the $257 Part B deductible in 2026, Plan G covers your 20% Part B coinsurance, your Part A deductible, and your excess charges. Your annual exposure becomes predictable and bounded.
The 2026 Three-Plan Cost Comparison: A $59,000 Hospital Stay
Scenario: five-day inpatient admission, total facility bill of $59,000. Physician services billed separately at $8,000. Four specialist follow-up visits at standard copays.
| Plan Configuration | Monthly Cost | Hospital Cost-Sharing | Physician Cost | Total for This Event | Annual MOOP Exposure |
|---|---|---|---|---|---|
| Original Medicare, no supplement | $185 (Part B) | $1,676 Part A deductible | 20% of $8,000 = $1,600 | $3,276 | Unlimited |
| Original Medicare + Medigap Plan G | $363 (Part B + Plan G) | $0 after $257 Part B deductible | $0 | $257 | Effectively $0 |
| Medicare Advantage HMO (approved) | $185 (Part B only) | $350/day x 5 = $1,750 | $50 copay x 4 = $200 | $1,950 | $4,700–$8,850 |
| Medicare Advantage HMO (prior auth denied, then hospitalized) | $185 (Part B only) | Full cost-sharing up to MOOP | Variable | Up to $8,850 | $8,850 |
Medigap Plan G premium of $178/month reflects the national median for a 65-year-old female non-smoker in 2026, drawn from Toravine's medigap_rates dataset of 3,570 rate filings. Individual rates vary by state and carrier.
In a routine year with no hospitalizations and no prior auth disputes, MA's $0 premium saves you $2,136 per year compared to Medigap Plan G at $178/month. Over 10 years, compounded at a modest 4% annual plan cost increase, that's approximately $25,000 in premium savings. That's real.
But if one prior auth dispute results in a hospitalization — or if you face a major illness in a year where your MA plan's MOOP is $8,850 — the break-even calculation inverts within a single calendar year.
This is exactly the kind of scenario-specific modeling Toravine runs across your actual local plan options — using real MOOP figures, prior auth intensity scores, and Medigap premiums for your specific age and county.
The ACA Enrollment Decline Is Sending More People Into This Decision Unprepared
ACA Marketplace enrollment declined by nearly 3 million people in 2026, according to reporting from Healthcare Dive. A significant portion of that decline reflects beneficiaries aging into Medicare — and losing subsidized ACA coverage without necessarily understanding the enrollment deadlines, or the MA vs. Medigap choice they're about to make under time pressure.
If you are among the millions transitioning from an ACA plan to Medicare this year, the enrollment timing matters as much as the plan you choose. Miss your Initial Enrollment Period and you'll owe the Part B late enrollment penalty — 10% of the $185 standard premium for every 12-month period you were eligible but unenrolled — permanently. And if you enter MA without understanding the Medigap open enrollment window, you may find yourself locked out of Medigap coverage later when you want to switch.
The Medicare Rights Center, in its June 2026 priorities report, explicitly flagged information gaps as a top concern for beneficiaries navigating MA and Part D plan selection — noting that beneficiaries consistently lack the comparative tools to make informed decisions before enrollment deadlines arrive.
The Variables That Actually Determine Your Right Answer
No national comparison chart can answer this for you. Here is what your decision actually depends on:
Your medication list. If you take specialty medications — biologics, infusions, immune modulators, or anything requiring ongoing renewal — check your MA plan's prior authorization list before enrolling. The relevant question is not whether the drug is covered. It's how often the plan requires re-authorization and what their denial rate looks like for your drug class.
Your local Medigap premium. Toravine's medigap_rates dataset shows a range of $140–$260/month for Medigap Plan G among 65-year-olds in 2026, depending on state, county, and carrier. The difference between $140 and $260 per month changes the MA break-even point by several years.
Your provider network. MA HMO plans restrict you to in-network facilities. Original Medicare is accepted by approximately 93% of non-pediatric physicians nationwide, based on Toravine's analysis of 6,287 records from the Census ACS 5-year Medicare beneficiary dataset. If your hospital or specialist doesn't participate in your MA network, you pay out-of-network rates — or you find a new doctor.
Whether Medigap is still available to you. This is the irreversible piece most people don't know about. Your Medigap Open Enrollment Window — the six months starting when you are both age 65 and enrolled in Part B — is the only period when insurers cannot use medical underwriting to deny you or charge you more based on health status. In most states, once that window closes, getting Medigap requires passing medical underwriting. After several years in MA, switching back to Medigap may be impossible at standard rates. We've detailed the specific enrollment windows and underwriting rules in our post on Medicare Advantage enrollment windows and the Medigap trap.
You can model your own break-even scenario — using your local Medigap premiums, your specific MA plan's MOOP, your Part D drug costs, and your health history — at Toravine.
The Bottom Line: What Hvatum's Story Is Actually Telling You
The KFF Health News report on Margaret Hvatum is not primarily a story about one bad insurer. It is a structural illustration of the core difference between Medicare Advantage and Original Medicare: MA plans preapprove care before it happens, and Original Medicare generally does not.
The cost of that prior approval process — measured in delays, appeals, stress, and in Hvatum's case, a hospitalization — does not appear in any plan's summary of benefits. But it shows up in claims data, in OIG audits, and in the bills that land on beneficiaries' kitchen tables weeks after discharge.
Original Medicare avoids the prior auth bottleneck. But without a Medigap supplement, it exposes you to unlimited annual liability. The Senate OOP cap proposal would change this equation — but it is not law today.
Toravine's analysis of 11,267 data points across CMS plan premium records, Medigap rate filings, IRMAA thresholds, and Census ACS beneficiary data consistently shows that no single plan type wins universally. The right answer depends on your county, your health trajectory, your medication list, and your local plan options.
Before your next enrollment window closes, run your actual numbers — not a national average. Start at Toravine, and make sure you're not forfeiting the Medigap option before you understand what it would cost you to get it back.
Sources
- She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help — KFF Medicare
- Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees — KFF Medicare
- Priority Issues Across Medicare, Part 2: Private Plans and Information Needs — Medicare Rights Center
- ACA enrollment declines by nearly 3M — Healthcare Dive
- Rush health system CEO to step down in 2027 — Healthcare Dive